Literature DB >> 24573939

The molecular epidemiological study of colistin-only-sensitive strains in multi-drug resistant Acinetobacter baumannii.

Li Yang1, Lizhong Han, Jingyong Sun, Yunsong Yu, Yuxing Ni.   

Abstract

This paper reported the epidemiology of the colistin-only-sensitive Acinetobacter baumannii (COS-AB) in a tertiary teaching hospital in China. We analyzed the clinical data of 136 COS-AB isolates from June 2004 to May 2005 and collected 66 A. baumannii isolates in which 33 strains were COS-AB, and the rest were non-COS-AB. Random amplified polymorphic DNA (RAPD) analysis (primer ERIC2 and 272) showed that all COS-AB were identical, while pulsed-field gel electrophotesis (PFGE) analysis showed two separate genotypes of these COS-AB which were distinctly different from that of non-COS-AB. The COS-AB from burn wards showed the identical PFGE pattern which was distinguished from the genotype of COS-AB in other departments, mainly surgical systems. The cross-infection was severe and strict methods of disinfection and sterilization should be implemented. Meanwhile, the epidemiology of COS-AB in environment and patients should be closely monitored. The PFGE analysis is a reliable method of A. baumannii typing.

Entities:  

Year:  2007        PMID: 24573939     DOI: 10.1007/s11684-007-0083-6

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  15 in total

1.  Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates.

Authors:  G J Da Silva; G J Leitão; L Peixe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  [Carbapenemase detection in Acinetobacter baumannii clones resistant to imipenem].

Authors:  Lucía Gallego; Miren Josune Canduela; Elena Sevillano; Idoia Pujana; Felícitas Calvo; Adelaida Umaran; Gloria Martín
Journal:  Enferm Infecc Microbiol Clin       Date:  2004-05       Impact factor: 1.731

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.

Authors:  G Bou; G Cerveró; M A Domínguez; C Quereda; J Martínez-Beltrán
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.

Authors:  X Corbella; A Montero; M Pujol; M A Domínguez; J Ayats; M J Argerich; F Garrigosa; J Ariza; F Gudiol
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

6.  Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam.

Authors:  E S Go; C Urban; J Burns; B Kreiswirth; W Eisner; N Mariano; K Mosinka-Snipas; J J Rahal
Journal:  Lancet       Date:  1994-11-12       Impact factor: 79.321

7.  Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.

Authors:  S López-Hernández; T Alarcón; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

8.  Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit.

Authors:  R Melamed; D Greenberg; N Porat; M Karplus; E Zmora; A Golan; P Yagupsky; R Dagan
Journal:  J Hosp Infect       Date:  2003-01       Impact factor: 3.926

9.  Infection control strategies in a neonatal intensive care unit in Argentina.

Authors:  I Kurlat; G Corral; F Oliveira; G Farinella; E Alvarez
Journal:  J Hosp Infect       Date:  1998-10       Impact factor: 3.926

10.  Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria.

Authors:  Matthew E Falagas; Ioannis A Bliziotis; Sofia K Kasiakou; George Samonis; Panayiota Athanassopoulou; Argyris Michalopoulos
Journal:  BMC Infect Dis       Date:  2005-04-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.